Zestoretic and Lamisil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zestoretic (hydrochlorothiazide; lisinopril) and Lamisil (terbinafine hydrochloride). Common drug interactions include chronic kidney disease among females and dermatitis bullous among males.

The phase IV clinical study analyzes what interactions people have when they take Zestoretic and Lamisil. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Zestoretic?

Zestoretic has active ingredients of hydrochlorothiazide; lisinopril. It is often used in high blood pressure. eHealthMe is studying from 4,342 Zestoretic users. Check the latest studies of Zestoretic.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.



On Jul, 07, 2026

22 people who take Zestoretic and Lamisil together, and have interactions are studied.

Zestoretic and Lamisil drug interactions.

What are the common drug interactions of Zestoretic and Lamisil, by gender? *:

female:

  1. Chronic kidney disease
  2. Chest pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Cardiomegaly (increased size of heart than normal)
  5. Hypertensive heart disease
  6. Oedema (fluid collection in tissue)
  7. Diarrhoea
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Renal failure (kidney dysfunction)
  10. Abdominal discomfort

male:

  1. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  2. Dry throat
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Increased upper airway secretion
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Petechiae (a small red or purple spot caused by bleeding into the skin)
  7. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Vasculitis (inflammation of a blood vessel or blood vessels)

What are the common drug interactions of Zestoretic and Lamisil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiomegaly (increased size of heart than normal)
  2. Chest pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypertensive heart disease
  5. Oedema (fluid collection in tissue)
  6. Dry throat
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Increased upper airway secretion
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

60+:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Ataxia (loss of full control of bodily movements)
  5. Back pain
  6. Balance disorder
  7. Blindness unilateral
  8. Bradycardia (abnormally slow heart action)
  9. Breast abscess
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 45.45%
  2. Skin Infection: 5 people, 22.73%
  3. High Blood Cholesterol: 5 people, 22.73%
  4. Fungal Infection: 5 people, 22.73%
  5. Indigestion: 4 people, 18.18%
  6. Constipation: 3 people, 13.64%
  7. Dyspnea (difficult or laboured breathing): 3 people, 13.64%
  8. Pain: 3 people, 13.64%
  9. Gout (uric acid crystals building up in the body): 3 people, 13.64%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Zestoretic and Lamisil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zestoretic and Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zestoretic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zestoretic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamisil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; lisinopril and terbinafine hydrochloride (the active ingredients of Zestoretic and Lamisil, respectively), and Zestoretic and Lamisil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: